Skip to main content

Animations

MJFF Publications

6301 - 6310 of 8808 Results
Title
Year
  • Year
  • 2017
  • 2023
  • 2013
  • 2017
  • 2020
  • 2023
  • 2016
  • 2019
  • 2021
  • 2021
  • Summary Details
    OPEN
    Title: Kinetin Riboside and Its ProTides Activate the Parkinson’s Disease Associated PTEN-Induced Putative Kinase 1 (PINK1) Independent of Mitochondrial Depolarization
    Journal Name: Journal of Medicinal Chemistry
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1021/acs.jmedchem.6b01897
    Citation Count: 85
  • Summary Details
    RESTRICTED
    Title: Progression of clinical markers in prodromal Parkinson’s disease and dementia with Lewy bodies: a multicentre study
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1093/brain/awad072
    Citation Count: 80
  • Summary Details
    RESTRICTED
    Title: 5-HT1 receptor agonists for the treatment of L-DOPA-induced dyskinesia: From animal models to clinical investigation
    Journal Name: Basal Ganglia
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.baga.2012.12.002
    Citation Count: 6
  • Summary Details
    OPEN
    Title: The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson’s disease
    Journal Name: Acta Neuropathologica Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s40478-017-0456-2
    Citation Count: 87
  • Summary Details
    OPEN
    Title: Pathway-specific dysregulation of striatal excitatory synapses by LRRK2 mutations
    Journal Name: eLife
    Publisher: eLife Sciences Publications, Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.7554/elife.58997
    Citation Count: 49
  • Summary Details
    OPEN
    Title: Genetic Testing in Parkinson's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.29500
    Citation Count: 17
  • Summary Details
    OPEN
    Title: PREFACE: Divergent roles of ER stress in neurodegeneration and brain disorders
    Journal Name: Brain Research
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: publisher-specific-oa
    DOI - Digital Object Identifier: 10.1016/j.brainres.2016.09.014
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Polymerization of Oxidized DJ-1 via Noncovalent and Covalent Binding: Significance of Disulfide Bond Formation
    Journal Name: ACS Omega
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: publisher-specific-oa
    DOI - Digital Object Identifier: 10.1021/acsomega.9b00324
    Citation Count: 3
  • Summary Details
    OPEN
    Title: ATG4 family proteins drive phagophore growth independently of the LC3/GABARAP lipidation system
    Journal Name: Molecular Cell
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.molcel.2021.03.001
    Citation Count: 70
  • Summary Details
    RESTRICTED
    Title: Correction to A Single Amino Acid Determines the Selectivity and Efficacy of Selective Negative Allosteric Modulators of CaV1.3 L-Type Calcium Channels
    Journal Name: ACS Chemical Biology
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1021/acschembio.1c00368
    Citation Count: 2
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.